- Conditions
- Vaginal Atrophy
- Interventions
- Placebo, Prasterone (DHEA)
- Drug
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Eligibility
- 40 Years to 80 Years · Female only
- Enrollment
- 558 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014 – 2015
- U.S. locations
- 24
- States / cities
- Montgomery, Alabama • Tucson, Arizona • Sacramento, California + 19 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–8
of 8
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Hypoactive Sexual Desire Disorder
- Interventions
- Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal Insert
- Drug
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Eligibility
- 40 Years to 80 Years · Female only
- Enrollment
- 653 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 63
- States / cities
- Huntsville, Alabama • Mobile, Alabama • Tucson, Arizona + 53 more
- Conditions
- Vaginal Atrophy
- Interventions
- Placebo, DHEA
- Drug
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Eligibility
- 40 Years to 75 Years · Female only
- Enrollment
- 255 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 24
- States / cities
- Montgomery, Alabama • Tucson, Arizona • Sacramento, California + 20 more
- Conditions
- Menopause, Genitourinary Syndrome of Menopause, Vulvovaginal Atrophy, Menopause Syndrome, Dyspareunia
- Interventions
- Intrarosa, Placebos
- Drug
- Lead sponsor
- Center for Vulvovaginal Disorders
- Other
- Eligibility
- 40 Years to 80 Years · Female only
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2021
- U.S. locations
- 2
- States / cities
- Washington D.C., District of Columbia • New York, New York
- Conditions
- Vaginal Atrophy
- Interventions
- Placebo, DHEA (0.25%), DHEA (0.5%), DHEA (1.0%)
- Drug
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Eligibility
- 40 Years to 75 Years · Female only
- Enrollment
- 218 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 2
- States / cities
- Cleveland, Ohio • Norfolk, Virginia
- Conditions
- Vaginal Atrophy
- Interventions
- DHEA
- Drug
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Eligibility
- 40 Years to 75 Years · Female only
- Enrollment
- 530 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2012
- U.S. locations
- 31
- States / cities
- Montgomery, Alabama • Tucson, Arizona • Sacramento, California + 26 more
- Conditions
- Vaginal Atrophy
- Interventions
- Placebo, DHEA
- Drug
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Eligibility
- 40 Years to 75 Years · Female only
- Enrollment
- 450 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 32
- States / cities
- Montgomery, Alabama • Tucson, Arizona • Little Rock, Arkansas + 27 more
- Conditions
- Hypoactive Sexual Desire Disorder (HSDD)
- Interventions
- Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal Insert
- Drug
- Lead sponsor
- EndoCeutics Inc.
- Industry
- Eligibility
- 40 Years to 80 Years · Female only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2018 – 2019
- U.S. locations
- 10
- States / cities
- Huntsville, Alabama • San Diego, California • New London, Connecticut + 7 more